Project AMPED
This is a multi-year, mixed methods study in Nevada and New Mexico is examining the patterns, reasons for, and health concerns related to methamphetamine use and opioid use.
Topic: Stimulant Use Disorder
If you do not find what you are looking for try searching with a different term or contact us.
Clinical Considerations Assessing and Treating Stimulant Use in Specific Populations
This recorded webinar from the PS ROTA-R provides an overview on the clinical considerations for assessing and treating stimulant use disorders in specific populations.
The Impact of Opioid Use on Rural Communities and Effective Treatment Approaches and Recovery Supports (Part 1)
This recorded webinar from the PS ROTA-R provides an overview on the impact of stimulant use on non-metropolitan rural communities.
The Impact of Opioid Use on Rural Communities and Effective Treatment Approaches and Recovery Supports (Part 2)
This recorded webinar from the PS ROTA-R provides an overview on the impact of stimulant use on non-metropolitan rural communities.
Stimulant Trifold Brochures
Stimulant Information Brochures for Providers or Consumers help educate on stimulants, including the effects of stimulants use, pregnancy and stimulant use, and treatment options for persons using stimulants.
Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders (January 10, 2024)
NIH-supported findings suggest the need to expand definitions of addiction treatment success beyond abstinence.
Stimulants in an Opiate World: SELF-PACED ONLINE COURSE
This online course from CASAT Learning offers 4 continuing education units and covers: changing trends on the use of stimulants and opiates; pharmacological properties of stimulants and the effects of stimulants on the central nervous system and the brain; specific treatment challenges associated with the use of opiates versus the use of stimulants; myths associated with stimulant use; potential biases about stimulant users; and the impact of agency policy on client access to care.
Understanding Stimulant Use and Stimulant Use Disorder Care
Hosted by UBC Health and the BC Centre on Substance Use, this webinar on Understanding Stimulant Use and Stimulant Use Disorder Care showcased an interprofessional panel of clinicians and peers who provided insights on stimulant use, the cultural factors related to stimulant use, harm reduction resources, and evidence-based treatment options for individuals experiencing stimulant use disorder.
Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?
In this presentation from Columbia Psychiatry, Dr. Steven Shoptaw, PhD focuses on the epidemiology, neurobiology, and treatment of stimulant use disorders.
Get the facts on Stimulant Use Disorder
Stimulant use disorder (StimUD) is a substance use disorder involving any of the class of drugs that include cocaine, methamphetamine, and prescription stimulants.
Fast Facts About Substance Use Disorders: What Every Nurse, APRN, and PA Needs to Know (Book)
This resource is the first to provide evidence-based information and strategies for APRNs and PAs who work with individuals with substance use disorders (SUDs). Written in a concise, bulleted style for easy access to critical information, the reference addresses often-undiagnosed medical and psychiatric conditions which may accompany SUDs and the ethical considerations of working with affected patients and families.
Current Diagnosis & Treatment: Psychiatry, 3e: Chapter 51: Stimulant Use Disorders
Leeman RF, Sofuoglu M. Stimulant Use Disorders. In: Ebert MH, Leckman JF, Petrakis IL. eds. Current Diagnosis & Treatment: Psychiatry, 3e. McGraw-Hill Education; 2019. Accessed April 19, 2024. https://accessmedicine.mhmedical.com/content.aspx?bookid=2509§ionid=200980686
Psychiatric Annals: Stimulant Use Disorders
Avellaneda-Ojeda, A., Murtaza, S., Shah, A. A., & Moukaddam, N. (2018). Stimulant use disorders. Psychiatric Annals, 48(8), 372–378. https://doi.org/10.3928/00485713-20180719-02
Drug Fact Sheet: Stimulants
This fact sheet from the DEA contains information on what stimulants are, common street names, how they are abused, their effect on the body, and their overdose effects.
The face of stimulant addiction: Who uses stimulants? (Infographic)
What does the typical stimulant user look like? In this infographic you can explore the age, gender, past year and past month meth use, polydrug use statistics, and emergency room visits.
SAMHSA’s TIP 33: Treatment for Stimulant Use Disorders
This TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.
SAMHSA’s Evidence-Based Resource Guide Series: Treatment of Stimulant Use Disorders
This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
Developed by ASAM and AAAP, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disorder, stimulant intoxication, and stimulant withdrawal.
Frontline: Meth and the Brain
In this audio slideshow, Dr. Rawson explains how meth affects the brain’s dopamine receptors, causing the intense pleasure associated with a meth rush and yet eventually making it impossible for the user to experience an pleasure at all. Richard A. Rawson, Ph.D is an Adjunct Associate Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California at Los Angeles.
U.S. Department of Veterans Affairs: Stimulant Use Disorder
Information on stimulant use disorder from the U.S. Department of Veterans Affairs.
Stimulant Abuse: Signs, Effects, and Treatment Options
This medically reviewed and evidence-based information from American Addiction Centers contains a broad overview of stimulants, including various types and effects, their addictive potential, and treatment options for stimulant misuse.
Centers for Disease Control and Prevention (CDC) Stimulant Guide
This guide will answer some common questions about stimulants, stimulant use, stimulant overdose, and stimulant overdose prevention strategies developed by harm reduction experts. Straightforward and concise answers are provided in an effort to convey the same key information to a variety of audiences. This document does not contain medical advice, nor should it be referred to in case of emergency. It is purely informational.
Good Samaritan Drug Overdose Act of 2015
The Good Samaritan Drug Overdose Act of 2015 (Senate Bill 459, Chapter 26, Statutes of Nevada 2015 NRS 453C.120) created various provisions addressing the opiate overdose epidemic that continues to claim over 300 lives per year in Nevada. The law prevents punitive actions against health professionals and any person who administers naloxone or calls 911 to assist someone who may be overdosing on opiates. It also provides immunity to persons seeking medical treatment for an opioid overdose for themselves or someone else. Learn more about the Good Samaritan Law.